Log in to save to my catalogue

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhi...

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37da49ca41554ae38f0bb80d40f404bf

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

About this item

Full title

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

Publisher

New York: Springer US

Journal title

Discover. Oncology, 2022-08, Vol.13 (1), p.73-73, Article 73

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Objectives
Response to immune checkpoint inhibitor (ICI) remains limited to a subset of patients and predictive biomarkers of response remains an unmet need, limiting our ability to provide precision medicine. Using real-world data, we aimed to identify potential clinical prognosticators of ICI response in solid tumor patients.
Methods
We...

Alternative Titles

Full title

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_37da49ca41554ae38f0bb80d40f404bf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37da49ca41554ae38f0bb80d40f404bf

Other Identifiers

ISSN

2730-6011

E-ISSN

2730-6011

DOI

10.1007/s12672-022-00538-6

How to access this item